Pathology and Immunology News
New oncogene linked to prostate cancer in African Americans may lead to better diagnostic tools, treatments Sep 2, 2016 New finding suggests that genetic factors can contribute, at last in part, to the higher incidence of prostate cancer among African American men compared with men of other ethnic groups.
Fifty-four mouse testis-enriched genes are not needed for male fertility Jun 27, 2016 New research into which genes are required for male fertility could lead to a better understanding of the genetic changes that lead to male infertility, and to design strategies to overcome them.
Baylor recognizes excellence among clinicians Jun 16, 2016 A select group of Baylor College of Medicine faculty members were recognized for excellence in patient care at the Master Clinician and Rising Star Clinician Awards ceremony.
Herbal remedies are an overlooked global health hazard May 2, 2016 Baylor College of Medicine is raising awareness that long-term use of herbal remedies is no guarantee of their safety.
Discovery of CTLA-4 in dendritic cells opens new possibilities to fight cancer Apr 4, 2016 Baylor College of Medicine researchers have discovered that CTLA-4 is produced and secreted by dendritic cells, which are the ‘generals’ of the T cells in the battle against cancer.
One atom can make a difference: Hydrogen-bonding pairing helps design better drugs to neutralize gut bacterial infections Mar 25, 2016 Researchers at Baylor College of Medicine have discovered that changing one atom in InsP6 can increase its ability to neutralize the toxins in Clostridium difficile Infections.
Immunology team receives prestigious Lee Howley Sr. Prize for arthritis research Nov 23, 2015 Baylor immunology team awarded the 2015 Lee Howley Sr. Prize that recognizes team science in action that will lead to a faster cure for arthritis and related diseases.
Center for Drug Discovery awarded grant from the Welch Foundation Aug 26, 2015 The DNA-encoded chemistry technology platform in the Center for Drug Discovery has been awarded a $2.8 million grant by the Welch Foundation to support discovering next-generation drugs.
Natural killer cell deficit plays role in common genetic disease Jun 16, 2015 Partial DiGeorge syndrome can result from the silencing of a number of genes that are important for controlling both virus-infected and tumor cells, said researchers led by those at Baylor College of Medicine.
Enzyme cuts path for T-cells to fight solid tumors Apr 13, 2015 T-cells specifically engineered to express enzyme heparanase have an improved ability to infiltrate the extracellular matrix surrounding solid tumors.